Hypogonadotropic hypogonadism (HH) is a condition where the body produces too little testosterone or estrogen because the brain fails to send the right hormonal signals to the sex organs. Unlike other forms of low sex hormones where the ovaries or testes themselves are damaged, HH starts higher up in the chain, in the hypothalamus or pituitary gland. The result is the same, low levels of sex hormones, but the cause and treatment options are distinct.
How the Hormonal Signal Chain Breaks Down
In a normally functioning system, a region of the brain called the hypothalamus releases a hormone called GnRH. That hormone travels a short distance to the pituitary gland, which responds by releasing two more hormones: FSH and LH. These two hormones then signal the testes to produce testosterone and sperm, or the ovaries to produce estrogen and release eggs. It’s a relay system, and every link matters.
In HH, the relay breaks at the brain level. Either the hypothalamus doesn’t produce enough GnRH, or the pituitary gland doesn’t respond to it properly. Without that upstream signal, FSH and LH stay low, and the ovaries or testes never get the message to do their job. This is why blood tests in people with HH show low sex hormones alongside low or “inappropriately normal” FSH and LH, a pattern that points directly to a brain-level problem rather than a problem with the gonads themselves.
How It Differs From Primary Hypogonadism
This distinction matters because it changes both the diagnosis and the treatment path. In primary hypogonadism (sometimes called hypergonadotropic hypogonadism), the testes or ovaries are damaged or dysfunctional. The brain recognizes the low hormone levels and ramps up FSH and LH in an attempt to compensate, so blood tests show high gonadotropin levels. In HH, the opposite pattern appears: FSH and LH are low or sit in the normal range even though sex hormone levels are clearly deficient. A testosterone level below 200 to 250 ng/dL in men is generally considered low, and values between 250 and 350 ng/dL are borderline. When those low numbers appear alongside low or normal FSH and LH, HH is the likely explanation.
This is a critical point that can be easy to miss. Normal-range FSH and LH readings might seem reassuring at first glance, but in the context of clearly low testosterone or estrogen, they are actually abnormal. The brain should be responding to the deficit by pushing those signals higher. When it doesn’t, that points to a hypothalamic or pituitary problem.
Congenital Causes: Born With the Condition
Some people are born with HH because the brain structures needed for this hormonal relay never developed properly. The most well-known form is Kallmann syndrome, which pairs delayed or absent puberty with a diminished or completely absent sense of smell. That unusual combination has a shared explanation: during fetal development, the nerve cells responsible for smell and the nerve cells that produce GnRH originate in the same area of the developing nose and migrate together into the brain. Mutations in any of more than 20 genes can disrupt that migration, leaving both the olfactory system and the GnRH system underdeveloped.
Mutations in genes including ANOS1, CHD7, FGF8, FGFR1, PROK2, and PROKR2 are among the most common culprits. Not everyone with congenital HH has smell problems, though. When the condition appears without any change to the sense of smell, it’s typically called normosmic idiopathic hypogonadotropic hypogonadism. The hormonal picture is the same; only the smell component differs.
Acquired Causes: Developing It Later in Life
HH can also develop in someone who previously went through normal puberty and had functioning sex hormones. Several things can damage or suppress the hypothalamic-pituitary relay after it has already been established.
- Pituitary tumors: A tumor in or near the pituitary gland can compress the tissue that produces FSH and LH. Surgery or radiation to treat a brain tumor can also damage the pituitary and trigger HH as a side effect.
- Medications: Opioid painkillers are one of the most common pharmaceutical causes. They suppress the hypothalamic signals that drive the entire chain. Some hormonal medications can do the same.
- Iron overload: A condition called hemochromatosis causes excess iron to accumulate in tissues, including the pituitary gland. Over time, that iron deposits damage the gland’s ability to function.
- Severe weight loss or extreme exercise: The hypothalamus is sensitive to energy balance. Prolonged calorie deficits or very high levels of physical stress can shut down GnRH release, which is one reason some endurance athletes and people with eating disorders lose their menstrual cycles or experience drops in testosterone.
In acquired cases, treating or removing the underlying cause (stopping an opioid, treating a tumor, correcting iron overload) can sometimes restore normal hormone function. When that isn’t possible, hormone replacement becomes the long-term approach.
Symptoms Before and After Puberty
The symptoms of HH depend heavily on when it starts. If the condition is present from birth or develops before puberty, the most obvious sign is that puberty simply doesn’t happen on schedule. In boys, this means the testes remain small, the voice doesn’t deepen, facial and body hair doesn’t appear, and muscle mass stays low. In girls, breasts don’t develop and menstruation never begins. Some children are also taller than expected because sex hormones normally signal the growth plates in bones to close, and without those hormones, the bones keep growing longer.
When HH develops after puberty, the symptoms are subtler and easier to attribute to other things. Men may notice declining energy, reduced sex drive, loss of muscle mass, and difficulty with erections. Women may experience irregular or absent periods, vaginal dryness, and decreased libido. Both sexes can develop mood changes, difficulty concentrating, and over time, weakening bones.
Impact on Bone Health
One of the most serious long-term consequences of untreated HH is bone loss. Sex hormones play a direct role in maintaining bone density, and without adequate levels, the skeleton gradually weakens. Studies have found that the prevalence of osteoporosis in men with hypogonadism is roughly double that of men with normal hormone levels (about 12% versus 6%). One study found that 58% of men with osteoporotic fractures were hypogonadal, compared with 18% of controls without fractures.
Testosterone replacement therapy can help reverse some of this damage. A meta-analysis of 29 randomized controlled trials involving over 1,000 men found that testosterone therapy improved bone mineral density at the lumbar spine by about 3.7% compared with placebo. Three studies specifically targeting men with low bone density found significant improvement with treatment. That said, no study has yet proven that testosterone replacement actually prevents fractures, so bone health monitoring remains important even during treatment.
Hormone Replacement for Symptom Relief
When the goal is simply to restore normal sex hormone levels and relieve symptoms, testosterone replacement is the standard approach for men. It comes in several forms. Daily topical gels are applied to the skin, typically starting at 50 mg per day and adjustable between roughly 20 and 100 mg depending on the formulation and blood test results. Injectable testosterone is given every one to two weeks, usually in the range of 50 to 200 mg per injection. A longer-acting injectable option is given less frequently, roughly every 10 weeks after an initial loading phase.
For women, estrogen replacement (often combined with progesterone) addresses symptoms like hot flashes, vaginal dryness, and bone loss. The specifics vary depending on age, whether the uterus is intact, and other individual factors.
Hormone replacement resolves most symptoms effectively, but it does not restore fertility. In men, external testosterone actually suppresses the small amount of remaining FSH and LH production, which can further reduce sperm counts. In women, it doesn’t trigger ovulation. Fertility requires a different strategy.
Restoring Fertility
Because the ovaries and testes themselves are typically healthy in HH, fertility is often achievable with the right treatment. The approach essentially bypasses the broken brain signal by providing the missing hormones directly.
For women, injectable gonadotropins (synthetic versions of FSH and LH) can stimulate the ovaries to develop and release eggs. Treatment typically starts at a low dose of 37.5 to 75 IU per day and is adjusted upward if the ovaries don’t respond after about a week. A typical cycle lasts 7 to 12 days, though some women need longer. Once a follicle reaches the right size, an injection of hCG triggers the final step of ovulation.
For men, a similar approach uses hCG injections (which mimic LH) to stimulate testosterone production within the testes, sometimes combined with FSH to jumpstart sperm production. This process is slower than ovulation induction in women. It can take 6 to 12 months or longer before sperm counts improve enough for conception. Men pursuing fertility need to stop any external testosterone therapy first, since it works against the very process they’re trying to restore.
The fact that fertility is often possible is one of the more hopeful aspects of HH. Unlike conditions where the gonads themselves are damaged, the reproductive organs in HH are usually just waiting for the right signal.